Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Cancer Chemotherapy and Pharmacology
|
February 23, 2015
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody
Georgina Meneses-Lorente, Thomas Friess, Irene Kolm, et al.
Cancer Research
|
June 16, 2016
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
Raphael Serre, Sebastien Benzekry, Laetitia Padovani, et al.
Cancer Research
|
June 29, 2017
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy
Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 25, 2021
A framework to guide dose & regimen strategy for clinical drug development
Oliver Sander, Baldur Magnusson, Inga Ludwig, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 31, 2015
Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis
Stephan Benay, Christophe Meille, Stefan Kustermann, et al.
Oncotarget
|
April 9, 2017
Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine
Dominique Barbolosi, Ilyssa Summer, Christophe Meille, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2014
Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approach
Brian Higgins, Kelli Glenn, Antje Walz, et al.
The AAPS Journal
|
January 5, 2017
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling
Nicole A Kratochwil, Christophe Meille, Stephen Fowler, et al.
British Journal of Cancer
|
June 18, 2021
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies
Sebastian Bauer, George D Demetri, Ensar Halilovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Eytan M Stein, Daniel J DeAngelo, Jörg Chromik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Cancer Chemotherapy and Pharmacology
|
February 23, 2015
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibody
Georgina Meneses-Lorente, Thomas Friess, Irene Kolm, et al.
Cancer Research
|
June 16, 2016
Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy
Raphael Serre, Sebastien Benzekry, Laetitia Padovani, et al.
Cancer Research
|
June 29, 2017
Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy
Joseph Ciccolini, Dominique Barbolosi, Christophe Meille, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
September 25, 2021
A framework to guide dose & regimen strategy for clinical drug development
Oliver Sander, Baldur Magnusson, Inga Ludwig, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
March 31, 2015
Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis
Stephan Benay, Christophe Meille, Stefan Kustermann, et al.
Oncotarget
|
April 9, 2017
Modeling therapeutic response to radioiodine in metastatic thyroid cancer: a proof-of-concept study for individualized medicine
Dominique Barbolosi, Ilyssa Summer, Christophe Meille, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2014
Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approach
Brian Higgins, Kelli Glenn, Antje Walz, et al.
The AAPS Journal
|
January 5, 2017
Metabolic Profiling of Human Long-Term Liver Models and Hepatic Clearance Predictions from In Vitro Data Using Nonlinear Mixed-Effects Modeling
Nicole A Kratochwil, Christophe Meille, Stephen Fowler, et al.
British Journal of Cancer
|
June 18, 2021
Pharmacokinetic-pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies
Sebastian Bauer, George D Demetri, Ensar Halilovic, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2021
Results from a First-in-Human Phase I Study of Siremadlin (HDM201) in Patients with Advanced Wild-Type TP53 Solid Tumors and Acute Leukemia
Eytan M Stein, Daniel J DeAngelo, Jörg Chromik, et al.
Page
of 3